Title: Yes, You Can Save Money By Reducing Blood Costs
1Yes, You Can Save Money By Reducing Blood Costs!
Supply Chain Performance Improvement
Presented by Priscilla R. Cherry, MBA,
MT(ASCP) Director, Laboratory Consulting Dennis
G. Sumwalt, MT(ASCP), CLDir Managing
Principal Supply Chain Performance Improvement
2Yes, You Can Save Money By Reducing Blood Costs!
- Agenda
- Introduction
- Blood Supply Demand
- Blood Costs
- Transfusion Safety
- Minimizing Transfusions
- Surgical Conservation
- Preoperative
- Intraoperative
- Postoperative
- Breakthrough Series 2007
3Yes, You Can Save Money By Reducing Blood Costs!
- Do healthcare organizations need to be concerned
about blood product use?
4Introduction
- Blood is a precious resource
- Two edge tool
- Life saving
- Life threatening
- Rational use
- Mantra right product at the right dose at the
right time for the right reasons - Ultimate goal
- Greater economy
- Greater effectiveness
- Greater safety
5Blood Conservation Management
- What
- Evidence based practice for minimizing
transfusion needs - Why
- Efficient allocation of scarce resources
- Prevention of transfusion related illness
- How
- Alterations in transfusion protocol
- Use of transfusion alternatives
6Blood Supply Demand
- Suitable Donors
-
- Testing Complexity
-
- Recruitment Expense
Cost
7Blood Supply Demand
- Adequacy of RBC supply depends on margin between
collections and transfusion - RBC transfusions increased 11.5 from 1994 to
1999 - Primary factors
- Aging population
- Increased oncologic transplantation demands
- Trend likely to continue
Source Transfusion.2005 Feb 45(2) 141-8.
8Blood Supply Demand
- Local Observations
- Demand for blood increasing
- Increasing surgical and medical therapeutic
options - Greater transplantation oncologic needs
- Aging population
- More access to complex medical and surgical
therapies - More resources consumed at end of life
- Blood demands
- National increase of 27 (1994 2001)
- Annual increase of 6 projected
9Blood Supply Demand
- Only 5 of eligible donors participate
- Donor restrictions increasing
- Travel (malaria, vCJD)
- Medications (Proscar)
- Emerging pathogens (SARS, West Nile Virus)
- Less support for blood drives
- Supply will not rise to meet continued increases
in demand
10Blood Supply Demand
- Costs The Future
- Cost of blood rose 37 in 2004
- Future increases are coming
- When blood hits 500, mark my words, every CEO
in the country is going to say he can reduce
utilization of blood products. - Bruce Speiss, Virginia Commonwealth University
11Blood Costs
- Procurement costs continue to rise
- 170 - 280 per unit is national range
- 70 of patients transfused have Medicare or
Medicaid or are uninsured - Reimbursement lags behind actual cost
- Because of capitation issues, economically it
does matter if patient gets 2 versus 4 units.
12Administrative Costs
- Procurement cost is only 20 of total costs
- Regulatory, testing, equipment, nursing, clerical
- Administrative costs are variable
- If no transfusion, cost is not incurred
- 2.25 hours of nursing clerical time for each
unit transfused
13Blood Donor Services
- American Red Cross
- Independent community blood banks
- Hospital donor services
- Frequently no competition in a community
- NBE for large users willing to work the spot
market
14Negotiable Donor Service Costs
- Purchased versus consigned units
- STAT delivery charges
- Autologous collection charges
- Inventory levels and age of units
- Packed Red Blood Cells (PRBCs) are most common
product - Expensive products single donor platelets
- Expensive products coagulation factors
15Transfusion Safety
- Infectious
- Viral transmission
- HIV, Hepatitis B, Hepatitis C
- Bacteria
- Prions
- Non-Infectious Serious Hazards of Transfusion
(NISHOT) - Blood mistransfusion
- Undertransfusion
- Neonatal metabolic risk
- Transfusion related immunomodulation (TRIM)
- Transfusion related acute lung injury (TRALI)
- Transfusion associated cardiac overload (TACO)
16Transfusion Safety
- Focus on viral transmission
- Real hazards lie elsewhere
- Mistransfusion
- TRIM (allogenic)
17Risk Assessment
- HIV transmission
- 1 unit in 2 million
- Accidental deaths general USA population
- Motor vehicle 1 in 6,300
- Bicycle 1 in 330,000
- Commercial airline 1 in 1.5 million
- Lightning 1 in 4 million
- Dog bite 1 in 9 million
18Risk Assessment
- Patient sample collection
- 1 in 165 mislabeled
- 1 in 1,155 contain wrong blood in tube
- Decision to administer transfusion
- Lack of physician education
- Lack of accessible criteria
- Bedside administration
- Mistransfusion leading cause of transfusion death
- 1 in 12,000 units mistransfused (estimate)
British Study
19Transfusion Related Immunomodulation (TRIM)
- Single highest risk factor
- 1.4 3.5 fold increase in post-op infections
- Single best predictor of post-op infections
- Dose dependent
- Matters whether 1 or 4 units are transfused
- Associated with cancer recurrence
20Conservation Safety
- Safest transfusion
- One not given
- Methods to ensure safety of blood supply
- Do not focus on enhancement of viral detection
- Prevent transfusion from being given unless
necessary
21How Can Transfusions Be Minimized?
- Education
- Institutional
- Guidelines
- Transfusion Triggers
- Maximum Surgical Blood Ordering Schedules (MSBOS)
- Review by Transfusion Practice Committee
- Interpersonal
- Formal
- Technology
- Drugs
- New techniques
22Where Do You Focus Your Energies?
- Emergency department
- Judgment in acute hemorrhage
- Difficult to evaluate or control practice
- Surgery
- Intensive care
- Random
- Most difficult to control
- Practioners who rarely transfuse
23Surgical Conservation
- Majority of blood use
- Surgery
- Oncology
- Cardiac surgery
- 20 of blood use (National statistic)
- Surgical conservation techniques require interest
by the surgical team - Anesthesia
- Perfusionist
- Surgeon
24Bloodless Medicine
- AABB Circular of Information
- Recommends that all physicians be familiar with
the alternatives - red cell containing components should not be
used to treat anemia's that can be corrected with
specific medications.. - Not a new concept
- Jehovah Witnesses
- Blood shortages
- Safe blood is unavailable
- Trauma
- Military field casualties
- Patients with multiple antibodies
- Patients with autoimmune hemolytic anemia
25Bloodless Medicine
- Philosophy
- Blood management
- Principles appropriate for all patients not just
special situations - Strategies
- Appropriate combination
- Drugs
- Technological devices
- Surgical medical techniques
- Interdisciplinary approach
- Individualized for each patient
- Goal
- Minimal transfusion in all patients
26Blood Conservation
27Surgery
- Preoperative Conservation
- Preoperative autologous donation
- EPO/Iron
- Restrict diagnostic phlebotomies
- Manage anticoagulation
- Avoid pharmacologic coagulopathies
- Surgical discretion
28Surgery
- Intraoperative Conservation
- Acute normovolemic hemodilution
- Cell salvage
- Electrocautery
- Ultrasonic energy
- Tissue dissectors
- Coagulation sealants
- Patient positioning
- Point of care testing
29Surgery / ICU
- Post-Operative
- Pharmacologic strategies
- Increasing endogenous RBC production
- Iron
- EPO
- Clinical strategies
- Reduced phlebotomies
- Judicious blood draws / smaller volumes drawn
- Acute normovolemic hemodilution (ANH)
- Return of blood post-surgery
- Restrictive transfusion for anemia of chronic
disease
30Transfusion Surveillance
- Data collection
- Data evaluation
- Education / Corrective Action
- Leads to
- CONFLICT
31Case Study
- Orthopedic Surgery Service - Netherlands
- Algorithm for reduction of transfusions
- Predefined transfusion triggers
- Selective COX-2 inhibitors
- Preoperative EPO and iron
- Cell salvage
- Aprotinin
- Results
- 80 reduction in transfusion rates
- 40 reduction in deep wound infections
Slappendel et al. Acta Orthop Scand 2003 74(5)
569-575
32Transfusion Guidelines
33Maximum Surgical Blood Ordering Schedules (MSBOS)
- Guideline Goals
- Acknowledge patient specific variability while
addressing physician and institution dependent
variables - Improve blood component management by developing
more physiologic clinical indicators of the need
for red blood cell transfusions - To Be Effective
- Guidelines for surgical red cell transfusion must
change physician behavior
34Transfusion Triggers
- Red Blood Cells (RBC)
- Examples of General Indications
- Varies with patient condition
- Acute loss of 15 of total blood volume
- Less than 9 g/dL with an expected loss of 500 mL
- Less than 8 g/dL in a patient on a chronic
transfusion regimen - Less than 7 g/dL in a critically ill patient
- Less than 10 g/dL in acute myocardial infarction
- Less than 10 g/dL in a patient with uremic
bleeding
35Transfusion Triggers
- Platelets
- Examples of General Indications
- Microvascular bleeding due to thrombocytopenia or
platelet dysfunction - Less than 10,000/µl chemotherapy induced
thrombocytopenia - Less than 20,000/µl solid tumor chemotherapy
patients - Less than 50,000/µl surgical or invasive
procedures patients
36Transfusion Triggers
- Fresh Frozen Plasma
- Examples
- Coagulation factor deficiency
- DIC
- Massive transfusions
- Liver disease
- PT and aPTT 1.5 times the mean reference range
37Coagulation Monitoring
38Coagulation Monitoring
- Improve blood product replacement therapy
- Operating rooms
- Cardiac surgery
- Hepatic transplantation
- Obstetrics
- Intensive cares
- Trauma centers
- Detect hypocoagulability
- Detect diffuse microvascular bleeding
- Identify appropriate patients for treatment
39Case Study
Transfused Product Cost 30 Patients before TEG
monitoring -VS- 30 Patients after TEG
monitoring (Data obtained from Harris HEB
Methodist Hospital, Bedford, Texas)
?140
?70
?211
?400
?325
Source Haemoscope Corporation - 2003
40Strategies to Reducing Blood Blood Product
Expenditures
- Transfusion Guidelines
- Physician Education
- Bloodless Medicine
412007 Breakthrough Series
Starting September 2006
- Blood Utilization Management and Conservation
- Learning Objectives
- Identify methods for preoperative, intraoperative
and postoperative methods for blood conservation - Identify tracking metrics and benchmarks that can
be used to monitor blood and blood product usage - Identify methods on working with physicians in
developing transfusion triggers and change
concepts for blood and blood product management - Program Participants
- Laboratory Medical Directors
- Laboratory Administrative Directors
- Laboratory Blood Bank Managers/Supervisors
- Transfusion Committee Physician Chairman's
- Physician Leads of Surgical Services
42(No Transcript)
43Contact Information
- Priscilla R. Cherry, MBA, MT(ASCP)
- Director, Laboratory Consulting
- Premier, Inc.
- Supply Chain Performance Improvement
- 704.733.5066
- Priscilla_cherry_at_premierinc.com
- Dennis G. Sumwalt, MT(ASCP), CLDir
- Managing Principal
- Premier, Inc.
- Supply Chain Performance Improvement
- 619.421.1380
- Dennis_sumwalt_at_premierinc.com
44Reference Information
45References
- Blood Matters, Vol. 6, No.4, October 2004.
Focus Platelet Transfusions.
www.bloodlink.bc.ca/bmoct04.pdf - Blood Transfusion Guidelines and Utilization
Review, Department of Pathology Medicine,
University of Michigan, June 2004.
www.pathology.med.umich.edu/bloodbank/manual/50003
.htm - Leukocyte-Reduced, Cytomegalovirus-Screened, and
Irradiated Blood Components Indications and
Controversies, Y Huh, MD, Current Issues in
Transfusion Medicine, April-June 1993.
www3.mdanderson.org/citm/H-93-04.html - Blood, Sweat, and Tears Improving quality,
safety and Cost, Premier Blood Forum 2001,
Premier, Inc. - Point of Care Monitoring of Haemostasis in the
OR and ICU, B. Ickx, Department of
Anaesthesiology, Hospital Erasme, Bruxelles,
Belgium, June 5, 2004. - Monitoring of Perioperative Dilutional
Coagulopathy Using the ROTEM Analyzer Basic
Principles and Clinical Examples, P Innerhofer,
W. Streif, G Kuhbacher, D. Fries, Transfusion
Medicine and Hemotherapy 200431244-249. - The Safe and Effective Use of Blood, K.G.
Badami, MD, 2004. www.sunmed.org/transfusion.html
46References
- Indications for Platelets Transfusion, Mike
Murphy, MD, National Blood Service, Oxford
Radcliffe Hospitals and University of Oxford for
the Clinical Transfusion Medicine Committee,
AABB, December 2004. - TEG Hemostasis Analyzer, Haemoscope ,
www.haemoscope.com - Strategies to Reducing Blood and Blood Products
Expenditures, P.Cherry, 2004, Premier, Inc. - Autologous Transfusion Clinical Practice based
on Scientific Knowledge, Schmerzther,
Anesthesiology Intensive Medicine, 2004 39 (11)
676-682. - Autologous blood donation, Goodnough, 2004
Critical Care 8(Cuppl 2) S49-S52 - New Game Plans for Taming Blood Use, A. Paxton,
CAP Today, College of American Pathologists,
2001, www.cap.org/apps/docs/cap_today/cover_storie
s/cov_1001.html - Quality Indicators of Blood Utilization Novis
et.al., Pathology and Laboratory Medicine, Vol.
126, No.2, pp.150-156. http//arpa.allenpress.com/
arpaonline - Bloodless medicine clinical care without
allogeneic blood transfusion, Goodnough et. Al.
Transfusion Medicine Vol. 43, May 2003, pp.
689-675.
47Common Benchmarks
- College of American Pathologist Q-Probe Studies
(2002) - CT ratios of 2.0 or less
- Red blood cell unit wastage below 0.5 percent
- Red blood cell unit expiration below 1.0 percent
- Blood component cost to operational expenses less
than 20
48Selected Tracking Metrics
- Crossmatch to transfusion ratio (CT)
- CT ratio by discipline/specialty
- Average red cell cost per case/DRG
- Average non red cell cost per case
- Average cost of all blood products per case
- Average blood bank expense per case
- Blood products per discharge
- Transfusion rates costs per discharge
49Information is Power
50Internal Resource Consumption Report
51Internal Resource Consumption by Physician,
Example
Clinical focus group Coronary artery bypass
graft (CABG) Quarter 2nd, 2004 IP/OP IP